Clinical trial NCT05519644: Strategies to Augment Ketosis: Ketone Conferred Resiliency Against Sleep Restriction
Official title: Strategies to Augment Ketosis: Ketone Conferred Resiliency Against Sleep Restriction
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Sleep Deprivation
Lead sponsor: Ohio State University
Sponsor class: OTHER
First posted: 2022-08-29
Enrollment: 60
Sex: ALL
Minimum age (years): 18
Maximum age (years): 40
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Intervention model description: A double-blind, placebo-controlled, two-period cross-over study
Primary purpose: BASIC_SCIENCE

Brief summary: Sleep deprivation is a major problem in military populations. Some major consequences of sleep loss are inability to concentrate, poor work efficiency, and increase in errors during daily tasks. There is some evidence that ketone ester supplements may lessen the adverse effects of sleep restriction. The main purpose of these supplements is to raise your blood concentration of ketones, which are safe, small molecules that appear in the blood during fasting, when following a ketogenic diet, or consuming ketone supplements.

The main purpose of this study is to examine if ingesting a ketone ester supplement, twice daily, can improve cognitive and physical performance during short-term sleep restriction.

Detailed description: Only 1 in 3 U.S. Army Active Component Soldiers are estimated to get the target =7-hr of sleep on duty days, and \~14% have a sleep disorder. Insufficient sleep has profound effects on human performance that include deficits in working memory, creativity, innovative thinking, strategic planning, mood disturbances, lapses in attention and vigilance, and impaired physical performance. In a classic dose-response sleep study performed at Walter Reed Army Institute of Research, it was demonstrated that limiting sleep to 3-hr per night for 7-days resulted in a steady deterioration on a psychomotor vigilance task across the week of sleep restriction. Sleep restriction over 3-days has been shown to adversely affect marksmanship performance, including significantly longer time to make decisions, misidentifying friends versus foes, and believing performance did not change over time. Short-term sleep restriction is linked with impaired glucose metabolism and decreased whole body insulin sensitivity, and increases the risk of developing T2D. Military personnel have few good options to counteract physical and cognitive detriments attributed to insufficient sleep. Warfighters increasingly turn to caffeine and sugar-containing energy drinks to combat sleep loss and fatigue, especially during deployment. At best, these nutritional countermeasures provide a transient performance gain, and may trigger a 'rebound' hypoglycemia that exacerbates performance detriments that can increase the risk of obesity and related problems. Ketosis could improve tolerance to sleep restriction and sleep abnormalities through multiple mechanisms. We have reported that a 1-yr KD improved sleep quality and the proportion of people categorized as poor sleepers. Ketones are a preferred brain fuel that may enhance neurocognitive function. The ability to metabolize a lipid-derived substrate (ketones) capable of sustaining the brain's high energy demands during periods with limited access to carbohydrate was a central adaptation in human evolution, that is also associated with a remarkable protection from the adverse signs of hypoglycemia. At the low end of nutritional ketosis (0.5 mM), \~5% of whole brain energy metabolism is provided by ketones. At ketone concentrations of 1.5 mM (typical of KDs), ketones supply nearly 20%; at the higher end of nutritional ketosis 4-5 mM \[achievable with ketone esters (KE)\], half of the brain energy demands are met by ketones. Importantly in situations where brain glucose metabolism is impaired, uptake and utilization of ketones remain fully intact, suggesting a hierarchy of importance placed on ketones as the preferred fuel for human brains.

Eligibility criteria: Inclusion Criteria:

* Participant is willing and able to comply with all study procedures including the following prior to Test Days: fasting (\>10 h; water only), no alcohol (\>24 h), no exercise (\>24 h), no acute illness and controlled feeding before each Test Day, maintain diet, exercise, medication, and supplement habits throughout the study.
* Participant has no health conditions that would prevent completion of the study requirements as judged by the Investigator based on health history.
* Participant understands the study procedures and signs forms providing informed consent to participate in the study and authorizes the release of relevant protected health information to the Investigator.

Exclusion Criteria:

* \<18 or \>40 years of age
* \>35 body mass index (BMI).
* Diagnosed sleeping disorders (i.e., sleep apnea, insomnia).
* Gastrointestinal disorders or food allergies that would interfere with consuming the study supplements.
* Drink alcohol in excess of 3 drinks/day or 14 drinks/week
* Have any conditions or contraindications to blood draws.
* Have been diagnosed with diabetes, liver, kidney, or other metabolic or endocrine dysfunction, or use diabetic medications other than metformin
* Currently consume a low carbohydrate or ketogenic diet or have done so in the last 3 months
* Have experienced weight loss of \>10% of your body weight within the last 6 months
* Are pregnant, lactating, or planning on becoming pregnant during the study
* Have any major psychiatric disorders (e.g., schizophrenia, bipolar disorder)

Primary outcomes:
measure: Automated Neuropsychological Assessment Metrics (ANAM)
timeFrame: Up to ~ 4 weeks
measure: Cambridge Neuropsychological Test Automated Battery. (CANTAB)
timeFrame: Up to ~ 4 Weeks
measure: Gradual-onset Continuous Performance Task (GRAD-CPT
timeFrame: Up to ~4 weeks
measure: Face-Name Task
timeFrame: Up to ~4 weeks
measure: Total number of shots fired
timeFrame: Up to ~4 weeks
measure: Percentage of targets successfully hit per minute
timeFrame: Up to ~4 weeks
measure: Radial distance of a shot from the center on target
timeFrame: Up to ~4 weeks
measure: Shot Group Tightness
timeFrame: Up to ~4 weeks
measure: Time from target presentation to trigger pull
timeFrame: Up to ~4 weeks
measure: Power Outcome (QuickBoard)
timeFrame: Up to ~4 weeks
Secondary outcomes:
measure: CGM/CKM
timeFrame: Up to ~ 4 weeks
measure: Heart Rate
timeFrame: Up to ~ 4 weeks
measure: Short Form- McGill Pain Questionnaire
timeFrame: Up to ~ 4 weeks
measure: Profile of Mood States- Short Form
timeFrame: Up to ~ 4 weeks
measure: Pittsburgh Sleep Quality Index
timeFrame: Up to ~ 4 weeks
measure: Insulin
timeFrame: Up to ~ 4 weeks
measure: Ghrelin
timeFrame: Up to ~ 4 weeks
measure: CRP
timeFrame: Up to ~ 4 weeks
measure: Brain Derived Neurotropic Factor
timeFrame: Up to ~4 weeks
Other outcomes:
Locations:
city: Columbus
country: United States
facility: The Ohio State University
state: Ohio
Study officials:
affiliation: Ohio State University
name: Jeff S Volek, PhD
role: PRINCIPAL_INVESTIGATOR
References: